What is it about?
Biotinidase deficiency is a treatable metabolic disease that can be seen with various neurological and dermatological complications.
Featured Image
Why is it important?
In cases with partial biotinidase deficiency, the heel blood alanine level that can be detected in the neonatal screening program may be a leading marker in diagnosis.
Perspectives
Read the Original
This page is a summary of: Investigation of alanine, propionylcarnitine (C3) and 3-hydroxyisovalerylcarnitine (C5-OH) levels in patients with partial biotinidase deficiency, Turkish Journal of Biochemistry, July 2019, De Gruyter,
DOI: 10.1515/tjb-2018-0340.
You can read the full text:
Resources
Contributors
The following have contributed to this page